Health‐Related Quality of Life in Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis: A Qualitative Study
Open Access
- 14 October 2025
- journal article
- Published by Wiley in JEADV Clinical Practice
- Vol. 5 (2) , 577-580
Abstract
Background: Epidermal necrolysis (EN), including Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), are severe cutaneous drug reactions with high morbidity. However, the quality of life (QoL) impact during acute hospitalization is not well understood. Objectives: To explore the acute QoL experience of EN patients and identify key domains to inform future QoL assessment tools and improve care. Methods: Twelve patients with confirmed EN were interviewed using a standardized script. Diagnoses were supported by histopathology and validated scoring systems. Interviews were analyzed thematically using NVivo software. Thematic saturation was reached after nine interviews. Results: Six QoL domains emerged: difficulties with activities of daily living, severe cutaneous symptoms, changes in physical appearance, painful oral symptoms, mental health challenges (e.g., anxiety, low mood), and medical distrust. Trimethoprim‐sulfamethoxazole was the most common culprit drug. All patients received systemic corticosteroids. Conclusions: These findings lay the groundwork for the development and validation of targeted quality‐of‐life assessment tools and support the need for holistic inpatient care strategies tailored to the physical, emotional, and relational disruptions experienced by patients with acute EN.Keywords
This publication has 5 references indexed in Scilit:
- The quality-of-life impact of Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on patients’ lives: an interpretative descriptive qualitative studyBritish Journal of Dermatology, 2024
- Long-term Physical and Psychological Outcomes of Stevens-Johnson Syndrome/Toxic Epidermal NecrolysisJAMA Dermatology, 2021
- Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adultsJournal of the American Academy of Dermatology, 2020
- Predictors of 30-day readmission in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cross-sectional database studyJournal of the American Academy of Dermatology, 2020
- Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysisBritish Journal of Dermatology, 2016